Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-21

Clinical Trial Update: Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated gabapentin for preventing chemotherapy-induced nausea and vomiting in adults with solid tumors; results have been posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED | Results posted: 2015-05-21